HPP AMG :@-0.828919:0.940294:-0.719701:0.940294:-0.719701:0.918072:-0.828919:0.918072:0.016043:0.013639:0.013639:0.005905:0.014867:0.022549:0.016672:0.005905
 Ocular Infections :@-0.092922:0.940294:0.099444:0.940294:0.099444:0.918072:-0.092922:0.918072:0.005938:0.017297:0.011183:0.013717:0.005879:0.012515:0.008857:0.005905:0.006584:0.013639:0.007708:0.013012:0.011314:0.008884:0.006010:0.013587:0.013717:0.010715:0.005905
 :@0.829525:0.940294:0.835430:0.940294:0.835430:0.918072:0.829525:0.918072:0.005905
58 :@0.802803:0.940294:0.835430:0.940294:0.835430:0.918072:0.802803:0.918072:0.013064:0.013658:0.005905
Oculoplasty :@-0.828919:0.144605:-0.657634:0.144605:-0.657634:0.122118:-0.828919:0.122118:0.021976:0.016019:0.017216:0.007724:0.017216:0.017786:0.007724:0.016019:0.016019:0.009492:0.016169:0.007924
Infection/ Condition :@-0.771318:0.190168:-0.541971:0.190168:-0.541971:0.171429:-0.771318:0.171429:0.006603:0.014181:0.007720:0.013064:0.013634:0.007720:0.006603:0.014751:0.014252:0.006603:0.006461:0.017197:0.014822:0.014252:0.014252:0.007102:0.007720:0.006603:0.014751:0.014454:0.006603
Suggested Treatment :@-0.162470:0.180084:0.087078:0.180084:0.087078:0.161345:-0.162470:0.161345:0.016010:0.014252:0.014252:0.014252:0.013064:0.013634:0.007720:0.013064:0.014822:0.006603:0.014181:0.009477:0.013064:0.013064:0.007720:0.021354:0.013634:0.014252:0.008527:0.006603
Comments :@0.558076:0.190168:0.687601:0.190168:0.687601:0.171429:0.558076:0.171429:0.017197:0.014252:0.021354:0.021354:0.013064:0.013658:0.008290:0.013753:0.006603
Preferred :@-0.300285:0.200252:-0.194466:0.200252:-0.194466:0.181513:-0.300285:0.181513:0.016010:0.007720:0.013064:0.007102:0.013064:0.007720:0.007720:0.013064:0.013753:0.006603
Alternative :@0.145249:0.200252:0.264086:0.200252:0.264086:0.181513:0.145249:0.181513:0.016010:0.004751:0.006603:0.012993:0.008290:0.013064:0.013064:0.007102:0.005273:0.011354:0.013729:0.006603
 :@-0.815261:0.220420:-0.808658:0.220420:-0.808658:0.201681:-0.815261:0.201681:0.006603
Dacryocystitis :@-0.815261:0.239748:-0.646485:0.239748:-0.646485:0.221008:-0.815261:0.221008:0.017197:0.013064:0.013064:0.009477:0.013064:0.014252:0.013064:0.013064:0.013634:0.007720:0.006603:0.007648:0.006603:0.013717:0.006603
 :@-0.815261:0.259126:-0.808658:0.259126:-0.808658:0.240387:-0.815261:0.240387:0.006603
 :@-0.479620:0.220420:-0.473017:0.220420:-0.473017:0.201681:-0.479620:0.201681:0.006603
Cefuroxime 250mg PO q12h for 7 days :@-0.479620:0.239748:-0.061758:0.239748:-0.061758:0.221008:-0.479620:0.221008:0.017197:0.013064:0.007102:0.012470:0.007720:0.013634:0.011283:0.004751:0.020760:0.013064:0.006603:0.012993:0.013064:0.013064:0.020166:0.013064:0.006603:0.015938:0.018409:0.006603:0.012993:0.013634:0.013634:0.012470:0.006603:0.007031:0.013064:0.007720:0.006603:0.012993:0.006603:0.013563:0.013634:0.011876:0.011283:0.006603
 :@-0.060855:0.239748:-0.054252:0.239748:-0.054252:0.221008:-0.060855:0.221008:0.006603
 :@-0.479620:0.259126:-0.473017:0.259126:-0.473017:0.240387:-0.479620:0.240387:0.006603
 :@0.005059:0.220420:0.011663:0.220420:0.011663:0.201681:0.005059:0.201681:0.006603
Amoxicillin/clavulanate 625mg PO :@0.005059:0.239748:0.370333:0.239748:0.370333:0.221008:0.005059:0.221008:0.016010:0.020166:0.013064:0.011283:0.004751:0.012447:0.005273:0.005392:0.005273:0.005392:0.012470:0.006603:0.012375:0.004751:0.013634:0.011876:0.013064:0.005273:0.013705:0.012470:0.013064:0.006603:0.013824:0.006532:0.013064:0.013064:0.013064:0.020166:0.013064:0.006603:0.015938:0.018409:0.006603
q8h for 7 days:@0.005059:0.259126:0.155226:0.259126:0.155226:0.240387:0.005059:0.240387:0.013064:0.013634:0.012470:0.006603:0.007031:0.013064:0.007720:0.006603:0.012993:0.006603:0.012993:0.013634:0.011876:0.011876
 :@0.155344:0.259126:0.161948:0.259126:0.161948:0.240387:0.155344:0.240387:0.006603
 :@0.423800:0.220420:0.430404:0.220420:0.430404:0.201681:0.423800:0.201681:0.006603
Consider intravenous antibiotics in :@0.423800:0.239748:0.791140:0.239748:0.791140:0.221008:0.423800:0.221008:0.017197:0.013064:0.013064:0.011876:0.005321:0.013064:0.013064:0.007720:0.007102:0.005273:0.012542:0.007102:0.007720:0.013634:0.011283:0.013634:0.013064:0.013634:0.013064:0.011283:0.006603:0.013563:0.013064:0.007102:0.004751:0.013634:0.004751:0.013064:0.007102:0.004751:0.012447:0.011283:0.007102:0.005273:0.012542:0.006603
severe infections:@0.423800:0.259126:0.601805:0.259126:0.601805:0.240387:0.423800:0.240387:0.011283:0.013634:0.011283:0.013634:0.007720:0.013064:0.007102:0.005273:0.012542:0.007102:0.013064:0.011876:0.007102:0.004751:0.013634:0.013064:0.011876
 :@0.602019:0.259126:0.608622:0.259126:0.608622:0.240387:0.602019:0.240387:0.006603
 :@0.423800:0.278454:0.430404:0.278454:0.430404:0.259714:0.423800:0.259714:0.006603
 :@-0.815261:0.298622:-0.808658:0.298622:-0.808658:0.279882:-0.815261:0.279882:0.006603
Preseptal Cellulitis :@-0.815261:0.317950:-0.596010:0.317950:-0.596010:0.299210:-0.815261:0.299210:0.016010:0.009477:0.013064:0.013064:0.013064:0.014252:0.007720:0.013064:0.006568:0.006532:0.017197:0.013064:0.007102:0.007102:0.013658:0.006603:0.007031:0.007720:0.006603:0.013753:0.006603
 :@-0.815261:0.337277:-0.808658:0.337277:-0.808658:0.318538:-0.815261:0.318538:0.006603
 :@-0.479620:0.298622:-0.473017:0.298622:-0.473017:0.279882:-0.479620:0.279882:0.006603
Amoxicillin/clavulanate 625mg PO q8h for :@-0.479620:0.317950:-0.033634:0.317950:-0.033634:0.299210:-0.479620:0.299210:0.016010:0.020166:0.013064:0.011283:0.004751:0.012447:0.005273:0.005392:0.005273:0.005392:0.012470:0.006603:0.012375:0.004751:0.013634:0.011876:0.013064:0.005273:0.013705:0.012470:0.013064:0.006603:0.013824:0.006532:0.013064:0.013064:0.013064:0.020166:0.013064:0.006603:0.015938:0.018409:0.006603:0.012993:0.013634:0.013064:0.006603:0.007031:0.013064:0.007720:0.006603
7 days :@-0.479620:0.337277:-0.402945:0.337277:-0.402945:0.318538:-0.479620:0.318538:0.013064:0.006603:0.012993:0.013634:0.011876:0.011900:0.006603
 :@-0.479620:0.356639:-0.473017:0.356639:-0.473017:0.337899:-0.479620:0.337899:0.006603
 :@0.005059:0.298622:0.011663:0.298622:0.011663:0.279882:0.005059:0.279882:0.006603
Ceftriaxone 1-2gm IV q24h  :@0.005059:0.317950:0.302090:0.317950:0.302090:0.299210:0.005059:0.299210:0.017197:0.013064:0.007102:0.006603:0.007648:0.004751:0.013634:0.011283:0.013634:0.013064:0.013064:0.006603:0.013135:0.007720:0.013634:0.013064:0.020166:0.006603:0.005867:0.016010:0.006603:0.013563:0.013064:0.013634:0.012470:0.007245:0.006603
 :@0.005059:0.337277:0.011663:0.337277:0.011663:0.318538:0.005059:0.318538:0.006603
 :@0.423800:0.298622:0.430404:0.298622:0.430404:0.279882:0.423800:0.279882:0.006603
Consider intravenous antibiotics in :@0.423800:0.317950:0.791140:0.317950:0.791140:0.299210:0.423800:0.299210:0.017197:0.013064:0.013064:0.011876:0.005321:0.013064:0.013064:0.007720:0.007102:0.005273:0.012542:0.007102:0.007720:0.013634:0.011283:0.013634:0.013064:0.013634:0.013064:0.011283:0.006603:0.013563:0.013064:0.007102:0.004751:0.013634:0.004751:0.013064:0.007102:0.004751:0.012447:0.011283:0.007102:0.005273:0.012542:0.006603
severe infections :@0.423800:0.337277:0.608622:0.337277:0.608622:0.318538:0.423800:0.318538:0.011283:0.013634:0.011283:0.013634:0.007720:0.013064:0.007102:0.005273:0.012542:0.007102:0.013064:0.011876:0.007102:0.004751:0.013634:0.013064:0.012090:0.006603
 :@-0.815261:0.376807:-0.808658:0.376807:-0.808658:0.358067:-0.815261:0.358067:0.006603
Orbital Cellulitis/abcess :@-0.815261:0.396134:-0.539596:0.396134:-0.539596:0.377395:-0.815261:0.377395:0.018409:0.009477:0.014252:0.006603:0.007648:0.013064:0.006603:0.006461:0.017197:0.013064:0.006603:0.007031:0.014252:0.006603:0.006461:0.007720:0.007102:0.013064:0.006603:0.013563:0.014252:0.013064:0.013064:0.013064:0.013836:0.006603
 :@-0.815261:0.415462:-0.808658:0.415462:-0.808658:0.396723:-0.815261:0.396723:0.006603
 :@-0.479620:0.376807:-0.473017:0.376807:-0.473017:0.358067:-0.479620:0.358067:0.006603
Amoxicillin/clavulanate 1.2gm q8h  IV for 7-:@-0.479620:0.396134:-0.024442:0.396134:-0.024442:0.377395:-0.479620:0.377395:0.016010:0.020166:0.013064:0.011283:0.004751:0.012447:0.005273:0.005392:0.005273:0.005392:0.012470:0.006603:0.012375:0.004751:0.013634:0.011876:0.013064:0.005273:0.013705:0.012470:0.013064:0.006603:0.013824:0.006532:0.013064:0.006603:0.012993:0.013064:0.020166:0.006603:0.012993:0.013634:0.013064:0.006603:0.007031:0.005938:0.016010:0.006603:0.007031:0.013064:0.007720:0.006603:0.013183:0.007910
10 days :@-0.479620:0.415462:-0.389881:0.415462:-0.389881:0.396723:-0.479620:0.396723:0.013064:0.013064:0.006603:0.012993:0.013634:0.011876:0.011900:0.006603
 :@-0.479620:0.434790:-0.473017:0.434790:-0.473017:0.416050:-0.479620:0.416050:0.006603
If Anaerobes suspected: :@-0.479620:0.454118:-0.217031:0.454118:-0.217031:0.435378:-0.479620:0.435378:0.005938:0.007102:0.006603:0.015938:0.013064:0.013064:0.013064:0.007720:0.013634:0.013064:0.013634:0.011283:0.007221:0.011876:0.013064:0.011283:0.013634:0.013064:0.011876:0.006532:0.013064:0.013064:0.007197:0.006603
 :@-0.479620:0.473479:-0.473017:0.473479:-0.473017:0.454739:-0.479620:0.454739:0.006603
ADD :@-0.479620:0.492387:-0.421354:0.492387:-0.421354:0.473647:-0.479620:0.473647:0.016627:0.017197:0.017838:0.006603
Metronidazole 500mg IV q8h for 7-10 :@-0.479620:0.511714:-0.070356:0.511714:-0.070356:0.492975:-0.479620:0.492975:0.019596:0.013064:0.006603:0.007648:0.013634:0.013064:0.005273:0.013135:0.013064:0.011876:0.013634:0.004751:0.013112:0.007102:0.013634:0.013634:0.013634:0.020760:0.013634:0.007102:0.006603:0.016532:0.007102:0.013634:0.014228:0.013064:0.007102:0.007696:0.013634:0.008290:0.007102:0.014086:0.008314:0.013658:0.013658:0.006603
days :@-0.479620:0.531042:-0.420760:0.531042:-0.420760:0.512303:-0.479620:0.512303:0.013634:0.013634:0.012447:0.012542:0.006603
 :@-0.479620:0.550370:-0.473017:0.550370:-0.473017:0.531630:-0.479620:0.531630:0.006603
 :@0.005059:0.376807:0.011663:0.376807:0.011663:0.358067:0.005059:0.358067:0.006603
Ceftriaxone 1-2gm q24h IV for :@0.005059:0.396134:0.330048:0.396134:0.330048:0.377395:0.005059:0.377395:0.017197:0.013064:0.007102:0.006603:0.007648:0.004751:0.013634:0.011283:0.013634:0.013064:0.013064:0.006603:0.013135:0.007720:0.013634:0.013064:0.020166:0.006603:0.012993:0.013064:0.013634:0.012470:0.007102:0.005938:0.016010:0.006603:0.007031:0.013064:0.008504:0.006603
 7-10 days :@0.005059:0.415462:0.122755:0.415462:0.122755:0.396723:0.005059:0.396723:0.006532:0.013064:0.007720:0.013064:0.013064:0.007102:0.013064:0.013634:0.011876:0.011971:0.006603
 :@0.005059:0.434790:0.011663:0.434790:0.011663:0.416050:0.005059:0.416050:0.006603
 :@0.423800:0.376807:0.430404:0.376807:0.430404:0.358067:0.423800:0.358067:0.006603
 :@-0.828919:0.570588:-0.822316:0.570588:-0.822316:0.551849:-0.828919:0.551849:0.006603
Reference: :@-0.828919:0.605008:-0.705938:0.605008:-0.705938:0.586303:-0.828919:0.586303:0.017197:0.013064:0.006603:0.012993:0.007720:0.013064:0.013064:0.012447:0.013064:0.007162:0.006603
1. :@-0.828919:0.639496:-0.802720:0.639496:-0.802720:0.620756:-0.828919:0.620756:0.013064:0.006532:0.006603
A 10 year review of Hospitalized children. Eur J Ophthalmol 2010;20(6): 1066-1072Microbiology and Antibiotic Management of Orbital Cellulitis Pediatrics :@-0.786164:0.639462:0.835891:0.639462:0.835891:0.620756:-0.786164:0.620756:0.016010:0.006603:0.012993:0.013064:0.006603:0.011805:0.013634:0.013064:0.008290:0.006603:0.007648:0.013064:0.011876:0.005321:0.013634:0.017197:0.006603:0.012993:0.007102:0.006603:0.017150:0.013064:0.011876:0.013064:0.005273:0.006603:0.013064:0.005273:0.005986:0.011283:0.013064:0.013634:0.006603:0.011805:0.013064:0.005273:0.005392:0.013634:0.007720:0.013064:0.013064:0.007102:0.006603:0.015938:0.013064:0.007720:0.006603:0.012375:0.006603:0.018337:0.013634:0.013064:0.006603:0.012993:0.013064:0.005914:0.019596:0.013064:0.005273:0.006603:0.013064:0.013634:0.013064:0.013064:0.006603:0.013563:0.013064:0.007720:0.013064:0.008290:0.006603:0.006461:0.013634:0.013064:0.013064:0.013789:0.008314:0.013064:0.013064:0.013064:0.013634:0.019596:0.005273:0.011924:0.007720:0.013064:0.013064:0.005914:0.013064:0.005273:0.013135:0.013064:0.011876:0.007102:0.013064:0.013064:0.013634:0.006603:0.015938:0.013064:0.006603:0.005273:0.013064:0.005273:0.013135:0.006603:0.005273:0.012447:0.006603:0.020095:0.013064:0.013064:0.013064:0.013064:0.013634:0.019596:0.013064:0.013064:0.007102:0.006603:0.012993:0.007102:0.006603:0.018337:0.007720:0.013064:0.005273:0.007173:0.013064:0.005273:0.007055:0.017197:0.013064:0.005273:0.005392:0.013064:0.005273:0.005392:0.006603:0.005273:0.011876:0.006532:0.016010:0.013634:0.013064:0.005273:0.013135:0.006603:0.007648:0.005273:0.011924:0.012447:0.006603
2011;127;e566 :@-0.786164:0.658840:-0.620950:0.658840:-0.620950:0.640134:-0.786164:0.640134:0.013064:0.013064:0.013064:0.013064:0.006603:0.013563:0.013064:0.013064:0.006603:0.012993:0.013634:0.013064:0.013765:0.006603
2. :@-0.828919:0.678202:-0.802720:0.678202:-0.802720:0.659462:-0.828919:0.659462:0.013064:0.006532:0.006603
CPG for Management of Post- Operative Endophthalmitis, Ministry of Health Malaysia, August 2006 :@-0.786164:0.678168:0.268836:0.678168:0.268836:0.659462:-0.786164:0.659462:0.017197:0.016010:0.018409:0.006603:0.006461:0.013064:0.007720:0.006603:0.019525:0.013064:0.013634:0.013064:0.013064:0.013064:0.020166:0.013064:0.013064:0.006603:0.006461:0.013634:0.006603:0.006461:0.016010:0.013064:0.011876:0.006805:0.007720:0.006532:0.018409:0.013634:0.013064:0.007720:0.013064:0.006603:0.005273:0.012447:0.013064:0.006603:0.015938:0.013064:0.013064:0.013064:0.013634:0.013064:0.006603:0.012993:0.013064:0.005273:0.019667:0.005273:0.006603:0.005321:0.012447:0.006603:0.006461:0.019596:0.005273:0.013135:0.005273:0.011924:0.006603:0.007648:0.011876:0.006532:0.013064:0.007102:0.006603:0.017150:0.013064:0.013064:0.005273:0.006603:0.013064:0.007102:0.019596:0.013064:0.005273:0.013135:0.011876:0.011876:0.005321:0.013064:0.006603:0.006461:0.016010:0.013634:0.013064:0.013064:0.011876:0.006532:0.006603:0.013563:0.013064:0.013064:0.014133:0.006603
3. :@-0.828919:0.697513:-0.802720:0.697513:-0.802720:0.678773:-0.828919:0.678773:0.013064:0.006532:0.006603
Sobrin L, Kump L, Foster CS. Intravitreal clindamycin for toxoplasmicretinochoroiditisRetina 2007. Sep;27(7): 952-7. :@-0.786164:0.697479:0.437530:0.697479:0.437530:0.678773:-0.786164:0.678773:0.016010:0.013064:0.013064:0.007720:0.005273:0.013135:0.006603:0.012993:0.006603:0.006461:0.016010:0.013064:0.020166:0.013064:0.006603:0.012993:0.006603:0.007031:0.014252:0.013064:0.011876:0.006532:0.013634:0.007720:0.006603:0.017150:0.016010:0.006603:0.007031:0.005938:0.013064:0.006603:0.008219:0.013064:0.011876:0.005321:0.006603:0.007648:0.013064:0.013064:0.005273:0.006603:0.011876:0.005321:0.005273:0.013705:0.013064:0.013064:0.019596:0.011876:0.011876:0.005321:0.013064:0.007102:0.006603:0.012993:0.007720:0.006603:0.007031:0.013064:0.011876:0.013064:0.013064:0.005273:0.013135:0.011876:0.019596:0.005273:0.011924:0.008290:0.013064:0.006603:0.005273:0.013064:0.013064:0.011876:0.013634:0.013064:0.007720:0.013064:0.005273:0.013135:0.005273:0.006603:0.005321:0.011876:0.017197:0.013064:0.006603:0.005843:0.013064:0.013064:0.006603:0.012993:0.013634:0.013064:0.013064:0.006603:0.006461:0.016010:0.013064:0.013064:0.007102:0.013064:0.013064:0.008290:0.013064:0.007720:0.006603:0.006461:0.013634:0.013064:0.014002:0.007743:0.013658:0.006508:0.006603
4. :@-0.828919:0.716840:-0.802720:0.716840:-0.802720:0.698101:-0.828919:0.698101:0.013064:0.006532:0.006603
Patrick MKT, Claire Y H, Susan L. Antiviral selection in the management of acute retinal necrosis. Clinical Ophthalmology 2010:4 11–20 :@-0.786164:0.716807:0.645439:0.716807:0.645439:0.698101:-0.786164:0.698101:0.016010:0.013064:0.006603:0.007648:0.005273:0.011924:0.011912:0.006532:0.019596:0.016010:0.014252:0.006603:0.006461:0.017197:0.005273:0.013135:0.005273:0.007791:0.013634:0.006603:0.015938:0.006603:0.017150:0.006532:0.006603:0.015938:0.013064:0.011876:0.013064:0.013064:0.006603:0.012993:0.007102:0.006603:0.015938:0.013064:0.006603:0.005273:0.011876:0.005321:0.007720:0.013064:0.005273:0.006603:0.011876:0.013064:0.005273:0.013135:0.011876:0.006532:0.005914:0.013064:0.013064:0.006603:0.005273:0.013064:0.006603:0.006461:0.013634:0.013064:0.006603:0.019525:0.013064:0.013064:0.013634:0.013064:0.013064:0.019596:0.013634:0.013064:0.006603:0.006461:0.013064:0.006603:0.007031:0.013064:0.011876:0.013064:0.006603:0.012993:0.007102:0.007720:0.013064:0.006603:0.005273:0.013064:0.013064:0.005273:0.007173:0.013064:0.013064:0.011876:0.008290:0.013064:0.011876:0.005321:0.011876:0.006532:0.006603:0.017150:0.005321:0.005273:0.013135:0.005273:0.011924:0.013064:0.005273:0.006603:0.018409:0.013064:0.013064:0.007102:0.013064:0.013064:0.005914:0.019596:0.013064:0.005273:0.013135:0.013064:0.011876:0.006532:0.013634:0.013064:0.013064:0.013064:0.006603:0.013563:0.006603:0.012993:0.014038:0.013658:0.013064:0.013658:0.006603
5. :@-0.828919:0.736168:-0.802720:0.736168:-0.802720:0.717429:-0.828919:0.717429:0.013064:0.006532:0.006603
Peter R, Jost H, Livia G, et al. Virus Diagnostics and Antiviral Therapy in Acute Retinal Necrosis ( ARN). Antiviral Drugs – Aspects of Clinical Use and :@-0.786164:0.736134:0.835772:0.736134:0.835772:0.717429:-0.786164:0.717429:0.016010:0.013064:0.006603:0.012993:0.007720:0.008290:0.017197:0.006603:0.008219:0.011876:0.013064:0.011876:0.006532:0.008290:0.017197:0.007102:0.008290:0.013064:0.005273:0.011924:0.005273:0.013135:0.008290:0.018409:0.006603:0.008812:0.013064:0.006603:0.008219:0.013064:0.005273:0.006603:0.008290:0.016010:0.005273:0.007791:0.013064:0.012447:0.008290:0.017197:0.005273:0.013135:0.013064:0.013064:0.013064:0.011876:0.006532:0.005273:0.011924:0.011876:0.008884:0.013064:0.013064:0.013064:0.008290:0.016010:0.013634:0.006603:0.005273:0.011876:0.005321:0.007720:0.013064:0.005273:0.008361:0.014252:0.013064:0.013634:0.007720:0.013064:0.013064:0.011876:0.008290:0.005914:0.013064:0.008290:0.016010:0.011876:0.013064:0.006603:0.012993:0.008290:0.017197:0.013064:0.006603:0.005273:0.013634:0.013064:0.005273:0.008361:0.017197:0.013064:0.011876:0.007720:0.013064:0.011876:0.005321:0.012447:0.008290:0.007720:0.008290:0.016010:0.017197:0.017197:0.007720:0.006603:0.008219:0.016010:0.013064:0.006603:0.005273:0.011876:0.005321:0.007720:0.013634:0.005273:0.008361:0.017197:0.007720:0.013064:0.013064:0.011876:0.009774:0.013135:0.008314:0.016010:0.011876:0.013088:0.013064:0.012447:0.006603:0.011805:0.008290:0.013064:0.006603:0.008219:0.017197:0.005273:0.005392:0.013064:0.005273:0.011924:0.013064:0.005273:0.008361:0.017197:0.011876:0.013634:0.008290:0.013064:0.013634:0.013634:0.006603
Recent Advances. Intechopen. :@-0.786164:0.755479:-0.455796:0.755479:-0.455796:0.736773:-0.786164:0.736773:0.017197:0.013064:0.011876:0.013064:0.013064:0.006603:0.006461:0.016010:0.013064:0.011876:0.013064:0.013064:0.012447:0.013064:0.011876:0.006532:0.007102:0.005938:0.013064:0.006603:0.012993:0.012447:0.013064:0.013064:0.013064:0.013634:0.013064:0.007399:0.006603
6. :@-0.828919:0.774874:-0.802720:0.774874:-0.802720:0.756134:-0.828919:0.756134:0.013064:0.006532:0.006603
Simon RJT, Robin H, Claire YH, Sue Lightman. Valacyclovir in the treatment of acute retinal necrosis. BMC Ophthalmology 2012, 12:48. :@-0.786164:0.774840:0.651378:0.774840:0.651378:0.756134:-0.786164:0.756134:0.016010:0.005273:0.019667:0.013064:0.013064:0.006603:0.017150:0.011876:0.014252:0.006603:0.006461:0.017197:0.013064:0.013064:0.005914:0.013064:0.006603:0.017150:0.006532:0.006603:0.017150:0.005321:0.013064:0.005273:0.007791:0.013064:0.006603:0.015938:0.017197:0.006603:0.006461:0.016010:0.013064:0.013064:0.007102:0.013064:0.005273:0.013135:0.013064:0.007102:0.019596:0.013064:0.013064:0.006603:0.006461:0.016010:0.013064:0.005273:0.013135:0.011876:0.011876:0.011876:0.005321:0.013634:0.011876:0.005321:0.007720:0.006603:0.005273:0.013064:0.006603:0.006461:0.013064:0.013064:0.006603:0.007031:0.007720:0.013064:0.013064:0.007102:0.019596:0.013064:0.013064:0.006603:0.007031:0.013064:0.006603:0.006461:0.013064:0.011876:0.013064:0.007102:0.013064:0.006603:0.007648:0.013064:0.006603:0.005843:0.013064:0.013064:0.005273:0.006603:0.013064:0.013064:0.012447:0.007720:0.013064:0.011876:0.005321:0.011876:0.006532:0.006603:0.015938:0.019596:0.017197:0.006603:0.018337:0.013634:0.013064:0.006603:0.012993:0.013634:0.005273:0.019667:0.013064:0.005273:0.013135:0.013064:0.011876:0.006532:0.013064:0.013634:0.013064:0.013064:0.007542:0.006532:0.013634:0.013064:0.006603:0.012993:0.013064:0.007150:0.006603
7. :@-0.828919:0.794202:-0.802720:0.794202:-0.802720:0.775462:-0.828919:0.775462:0.013064:0.006532:0.006603
Robert WW, Emmett TC et al. Diagnosing and Managing Acute Retinal Necrosis. Retinal Physician. :@-0.786164:0.794168:0.266461:0.794168:0.266461:0.775462:-0.786164:0.775462:0.017197:0.013064:0.013064:0.013064:0.007720:0.006603:0.006461:0.022542:0.022542:0.006603:0.006461:0.016010:0.019596:0.019596:0.013634:0.006603:0.006461:0.006603:0.014181:0.017197:0.006603:0.013563:0.006603:0.006461:0.013064:0.005273:0.006603:0.006532:0.017197:0.005273:0.013135:0.013634:0.013064:0.013064:0.011876:0.005321:0.013064:0.013064:0.007102:0.013064:0.013064:0.013064:0.007102:0.019596:0.013064:0.013064:0.013064:0.013064:0.005914:0.013064:0.013064:0.007102:0.016010:0.011876:0.013064:0.006603:0.012993:0.007067:0.017197:0.013064:0.006603:0.005273:0.013064:0.013064:0.005273:0.006603:0.017197:0.013064:0.011876:0.008290:0.013064:0.011876:0.005321:0.011876:0.006532:0.006603:0.017150:0.013064:0.006603:0.005273:0.013064:0.013064:0.005273:0.006603:0.016010:0.013064:0.011876:0.011876:0.005321:0.011876:0.005321:0.013634:0.013064:0.007435:0.006603